![Xiao Feng Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Feng Chen
Directeur/Membre du Conseil chez Guangdong HEC Biological Pharmacy Co., Ltd.
Provenance du réseau au premier degré de Xiao Feng Chen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Guangdong HEC Biological Pharmacy Co., Ltd.
![]() Guangdong HEC Biological Pharmacy Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong HEC Biological Pharmacy Co., Ltd. engages in the research, development, production, and sale of medicines and medical equipment. It also engages in the development of stem cell technology, stem cell drugs, and immune cell biotechnology. The company was founded on February 10, 2017 and is headquartered in Dongguan, China.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Xiao Feng Chen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Sunshine Lake Pharma Co. Ltd.
![]() Sunshine Lake Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shenzhen HEC Industrial Development Co., Ltd., Sunshine Lake Pharma Co. Ltd. is a Chinese company that manufactures and supplies pharmaceutical ingredients and drugs. The company is based in GD. Wen Jia Li has been the CEO of the company since 2021. Sunshine Lake Pharma Co. was acquired by Shenzhen HEC Industrial Development Co., Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. on December 23, 2022 for $330.99 million. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiques
Internationale
Chine | 2 |
Sectorielle
Health Technology | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Relations les plus connectées
Insiders | |
---|---|
Wen Jia Li | 2 |
- Bourse
- Insiders
- Xiao Feng Chen
- Connexions Sociétés